King of Generics Pushes Into Biotech Drugs

Israel’s Teva, the world’s largest maker of generic drugs, is looking for growth in an unlikely place: high-price biotech medicines.

from WSJ.com: US Business https://on.wsj.com/2tl6tKZ
via IFTTT